Status:

RECRUITING

REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)

Lead Sponsor:

Acandis GmbH

Conditions:

Rescue Stenting

Eligibility:

All Genders

18+ years

Brief Summary

Goal of the study is to evaluate the efficacy and safety of acute permanent stenting of symptomatic intracranial stenosis following unsuccessful recanalization by thrombectomy in acute ischemic stroke...

Eligibility Criteria

Inclusion

  • Patients, treated with CREDO® heal according to IFU
  • Over 18 years old
  • With acute persistent vascular occlusion due to high grade intracranial artery stenosis in the anterior or posterior circulation for which alternative therapy concepts are not considered or fail
  • With suspected underlying stenosis of the occluded artery, which is suitable for PTA and stenting according to the treating physician's assessment and/or persistent occlusion after failed recanalization by mechanical thrombectomy of the target region
  • With small to moderate infarct core prior to initiation of thrombectomy (CT ASPECTS 6-10, DWI lesion \< 70 ml)
  • With symptoms onset less than 24 hours before start of the procedure
  • Treated with study device following at least one futile mechanical recanalization attempt with a stent retriever, direct aspiration or combination of both
  • With pre-stroke disability mRS 0-2

Exclusion

  • Any contraindication according to IFU and patients:
  • With atherosclerotic (probable according to clinical, anamnestic or laboratory chemical testing) vessel constrictions (high-grade intracranial stenoses \> 70 %) with significant circulatory disturbance (haemodynamic infarct pattern and signs of restricted collaterals) and recurrent symptoms in spite of medical therapy
  • With contraindication against treatment with anti-platelet medication
  • Participating in another trial

Key Trial Info

Start Date :

January 25 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2027

Estimated Enrollment :

153 Patients enrolled

Trial Details

Trial ID

NCT05345483

Start Date

January 25 2023

End Date

January 1 2027

Last Update

December 5 2024

Active Locations (17)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (17 locations)

1

Institut für Radiologie und Neuroradiologie, Klinikum Aschaffenburg-Alzenau

Aschaffenburg, Germany, 63739

2

Klinik für Diagnostische Radiologie und Neuroradiologie; Universitätsklinikum Augsburg

Augsburg, Germany, 86156

3

Klinik für Diagnostische und Interventionelle Neuroradiologie; Universitätsklinikum Bonn

Bonn, Germany

4

Institut für Diagnostische und Interventionelle Radiologie, Neuroradiologie und Nuklearmedizin, Klinikum Bremerhaven-Reinkenheide

Bremerhaven, Germany